JAV Insider Trading Activity and SEC Form 4 Filings
JAV insider trading summary
No open-market insider purchases or sales of Javelin Pharmaceuticals, Inc (JAV) have been reported on SEC Form 4 in the past 12 months.
Latest JAV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 3, 2010 | Daniel B Carr | President and CMO | Sell | $40K (18,450 @ $2.18) |
| May 3, 2010 | Stephen J Tulipano | CFO and Secretary | Sell | $5K (2,385 @ $2.18) |
| Mar 26, 2010 | Daniel B Carr | President and CMO | Sell | $945 (700 @ $1.35) |
| Mar 25, 2010 | Daniel B Carr | President and CMO | Sell | $6K (4,700 @ $1.35) |
| Mar 19, 2010 | Martin J Driscoll | Chief Executive Officer | Buy | $29K (22,181 @ $1.30) |
| Mar 3, 2010 | Neil Flanzraich | Director | Buy | $119K (84,580 @ $1.41) |
| Feb 19, 2010 | Neil Flanzraich | Director | Buy | $142K (100,000 @ $1.42) |
| Feb 18, 2010 | Neil Flanzraich | Director | Buy | $16K (11,000 @ $1.42) |
| Feb 16, 2010 | Neil Flanzraich | Director | Buy | $68K (50,000 @ $1.36) |
| Feb 12, 2010 | Martin J Driscoll | Chief Executive Officer | Buy | $8K (6,331 @ $1.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.